Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin.

MLA

Arendrup, Maiken Cavling, et al. “Multicentre Validation of a Modified EUCAST MIC Testing Method and Development of Associated Epidemiologic Cut-off (ECOFF) Values for Rezafungin.” Journal of Antimicrobial Chemotherapy (JAC), vol. 78, no. 1, Jan. 2023, pp. 185–95. EBSCOhost, https://doi.org/10.1093/jac/dkac373.

APA

Arendrup, M. C., Arikan-Akdagli, S., Castanheira, M., Guinea, J., Locke, J. B., Meletiadis, J., & Zaragoza, O. (2023). Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin. Journal of Antimicrobial Chemotherapy (JAC), 78(1), 185–195. https://doi.org/10.1093/jac/dkac373

Chicago

Arendrup, Maiken Cavling, Sevtap Arikan-Akdagli, Mariana Castanheira, Jesus Guinea, Jeffrey B Locke, Joseph Meletiadis, and Oscar Zaragoza. 2023. “Multicentre Validation of a Modified EUCAST MIC Testing Method and Development of Associated Epidemiologic Cut-off (ECOFF) Values for Rezafungin.” Journal of Antimicrobial Chemotherapy (JAC) 78 (1): 185–95. doi:10.1093/jac/dkac373.